This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • The impact of acute intradialytic exercise on cardioprotection

  • Treating anaemia in patients receiving peritoneal dialysis – vadadustat shows potential as oral alternative over intravenous treatments

  • Digital physical activity and emotional well-being intervention: Kidney BEAM trial design and baseline data

  • Sodium–glucose cotransporter 2 inhibitors in heart failure: does it matter how they work?

  • EMPA-VISION: Cardiac energy in people with heart failure taking empagliflozin

  • Chronic kidney disease and incident heart failure: insights from the Atherosclerosis Risk in Communities study

  • Haemodialysis-related acute brain injury

  • Optimising heart failure treatment for patients on peritoneal dialysis

    Optimising heart failure treatment for patients on peritoneal dialysis

  • Sacubitril/valsartan in peritoneal dialysis patients

    Sacubitril/valsartan in peritoneal dialysis patients

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe